- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Small Caps
U.S. Pharmaceuticals & Biotech Undervalued Small Caps
Results
3
0 new
Undervalued Small Caps
3 companies
Zevra Therapeutics
Market Cap: US$665.0m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.00
7D
8.2%
1Y
41.2%
Abeona Therapeutics
Market Cap: US$341.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.77
7D
5.7%
1Y
5.1%
SIGA Technologies
Market Cap: US$337.1m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$4.73
7D
2.8%
1Y
-13.1%